Video

Dealing with the Isolation of Cancer Treatment

Larry Whipple had to travel 1,500 miles from his hometown for a second opinion after he was diagnosed with advanced lung cancer, but through the course of his treatment he had to remain in isolation to avoid further illness.

After receiving a diagnosis of advanced lung cancer, Larry Whipple became his best own advocate by asking the right questions and seeking the most qualified experts — including finding a second opinion nearly 1,500 miles from his hometown. But as he soon found out the diagnosis, he realized his journey would be a difficult one, mostly due to his need to live in isolation to keep his immune system as healthy as possible.

Here, Whipple explains how his approach to isolation helped him get through the tough times, mainly by managing his expectations. “If you manage your expectations and you can manage them effectively,” Whipple says, “you can be a pretty happy and content person, because you’re not disappointed.”

Transcription:

The chemotherapy (severely weakens) your immune system. Once the chemo started, I literally was quarantined for about six months.

Seriously, I mean, I didn’t go out of the home. My wife and I didn’t do any socializing. We saw my son and daughter-in-law once in a while. They have four children, so I didn’t really want to be exposed in any way. The isolation was very difficult. The actual treatment was a cakewalk. It had absolutely zero effect. You can see my coiffure here: That’s by choice and genetics; it has nothing to do with chemo.

I’ve learned in life that happiness and contentment is all related to what your expectations are. So, if you manage your expectations and you can manage them effectively, you can be a pretty happy and content person, because you’re not disappointed.

Related Videos
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.